Modified high-performance liquid chromatographic method to measure both dextromethorphan and proguanil for oxidative phenotyping

This publication has 16 references indexed in Scilit:

• Nomenclature for human CYP2D6 alleles
  Pharmacogenetics, 1996
• Simultaneous Determination of Dextromethorphan and Dextrorphan in Human Plasma, Urine and Cerebrospinal Fluid by HPLC with Fluorescence Detection
  Journal of Liquid Chromatography & Related Technologies, 1996
• Quantification of dextromethorphan and metabolites: a dual phenotypic marker for cytochrome P450 3A4/5 and 2D6 activity
  Journal of Chromatography B: Biomedical Sciences and Applications, 1996
• High-Performance Liquid Chromatography Determination of Dextromethorphan and Dextrorphan for Oxidation Phenotyping by Fluorescence and Ultraviolet Detection
  Therapeutic Drug Monitoring, 1993
• Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans
  Clinical Pharmacology & Therapeutics, 1992
• The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism.
  British Journal of Clinical Pharmacology, 1990
• Simultaneous Determination of Dextromethorphan and Three Metabolites in Plasma and Urine Using High-Performance Liquid Chromatography with Application to Their Disposition in Man
  Therapeutic Drug Monitoring, 1990
• Inter‐subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.
  British Journal of Clinical Pharmacology, 1989
• Phenotyping polymorphic drug metabolism in the French Caucasian population
  European Journal of Clinical Pharmacology, 1988
• Polymorphic dextromethorphan metabolism: Co-segregation of oxidative O-demethylation with debrisoquin hydroxylation
  Clinical Pharmacology & Therapeutics, 1985